The Government is to commit £15m to a new fund to boost dementia research, it was announced today. The fund, which will focus on research to develop new treatments for dementia, will aim to bring in further investment from the private and charity sectors to back a range of research projects.
Government announces £15m dementia research fund
Alzheimer’s Research UK is leading the way finding new treatments, and has recently launched a range of initiatives – including pioneering Drug Discovery Institutes and a Global Clinical Trials Fund – to bring new treatments to patients sooner. The charity has welcomed the Government’s announcement, which comes a year after the UK used its presidency of the G8 to hold the first Dementia Summit to find ways to tackle the condition. The summit saw the G8 countries commit to an aim to find a disease-modifying treatment by 2025.
Hilary Evans, Director of External Affairs at Alzheimer's Research UK, the UK’s leading dementia research charity, said:
"Alzheimer's Research UK welcomes today's announcement of extra investment in research, this represents another step forward in the fight to tackle what is our greatest health challenge and a devastating condition. The treatments available for people with dementia offer scant relief and are simply not good enough – we need a therapy that acts to slow or stop disease in its tracks. If we could produce a treatment that delayed onset by five years, a third fewer people would ever experience the devastation of dementia.
“The new funds complement Alzheimer's Research UK's own major investment in dementia drug discovery and our efforts to end the tortuous wait for an effective treatment that people deserve."
Alzheimer’s Research UK is the UK’s leading dementia research charity. We fund innovative research with the power to transform lives, campaign for government action, and help people to understand dementia and the progress we’re making with research.
Our people are vital to our mission. Our pioneering spirit is reflected in the energy and drive of our staff – all of whom play a key role in helping realise our vision of a world where people are free from the fear, harm and heartbreak of dementia.
By working at Alzheimer’s Research UK, you will be part of an organisation that has been recognised nationally as an outstanding place to work. In 2020, we were listed 39th in the prestigious Sunday Times 100 Best Not-for-Profit Organisations to Work For. We were also awarded a 2-star accreditation by Best Companies, recognising outstanding levels of workplace engagement and were listed in the 75 Best Companies to Work For in the East of England.